Repligen (RGEN)
Supplies filtration, chromatography, analytics, and protein technologies for biologics manufacturers and CDMOs.
$182.53
vs last close−4.22 (−2.26%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 141 | 156 | 153 | 159 | 155 | 168 | 169 | 182 | 189 | 198 | 194 | 204 |
| Cost of revenue | 105 | 88 | 76 | 86 | 77 | 129 | 78 | 91 | 88 | 104 | 96 | 96 |
| Gross profit | 37 | 68 | 77 | 73 | 77 | 39 | 91 | 91 | 101 | 93 | 98 | 108 |
| 32 | 68 | 73 | 66 | 85 | 75 | 84 | 77 | 84 | 75 | 80 | 96 | |
| Research & development | 11 | 10 | 11 | 10 | 10 | 12 | 13 | 14 | 14 | 12 | 14 | 14 |
| 56 | 58 | 62 | 56 | 76 | 60 | 71 | 71 | 74 | 63 | 77 | 77 | |
| Selling & marketing | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | −34 | 1 | 0 | 0 | 0 | 3 | 0 | −8 | −4 | 0 | −11 | 5 |
| Operating income | 5 | −1 | 4 | 7 | −8 | −37 | 7 | 14 | 17 | 19 | 18 | 12 |
| 7 | −8 | 0 | 2 | 7 | −2 | 1 | 4 | 0 | 1 | −16 | 2 | |
| Interest income | 7 | 6 | 9 | 0 | 0 | 0 | 7 | 7 | 14 | 7 | 6 | 6 |
| Interest expense | 1 | 8 | 6 | 6 | 6 | 5 | 6 | 6 | 27 | 6 | 6 | −17 |
| Other non-operating income | −7 | 7 | −5 | −7 | −12 | −3 | −7 | −10 | −6 | −6 | 10 | −10 |
| Income before tax | 11 | −9 | 4 | 9 | −1 | −39 | 8 | 18 | 17 | 19 | 2 | 14 |
| Income tax expense | −6 | 17 | 0 | 3 | 0 | −5 | 2 | 3 | 2 | 6 | −7 | 9 |
| Net income from continuing operations | 17 | −25 | 3 | 6 | −1 | −34 | 6 | 15 | 15 | 13 | 8 | 5 |
| Net income | 17 | −25 | 3 | 6 | −1 | −34 | 6 | 15 | 15 | 13 | 8 | 5 |
| EPS, basic | $0.33 | −$0.46 | $0.04 | $0.06 | $0.32 | −$0.60 | $0.10 | $0.26 | $0.27 | $0.23 | $0.15 | $0.09 |
| EPS, diluted | $0.32 | −$0.46 | $0.04 | $0.06 | $0.32 | −$0.60 | $0.10 | $0.26 | $0.26 | $0.23 | $0.15 | $0.09 |
| Weighted average shares, basic | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 57 | 56 | 56 |
| Weighted average shares, diluted | 57 | 56 | 57 | 56 | 57 | 56 | 57 | 57 | 57 | 57 | 57 | 57 |
| EBITDA | 32 | 10 | 30 | 36 | 21 | 2 | 36 | 48 | 47 | 45 | 32 | −2 |
| Depreciation & amortization | 20 | 17 | 21 | 21 | 17 | 35 | 23 | 25 | 24 | 20 | 25 | −25 |
| EBIT | 12 | −8 | 9 | 15 | 4 | −33 | 13 | 24 | 23 | 25 | 8 | 22 |